Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children

Pediatrics

Volumn 105, Issue 3, 2000, Pages 608-614

  DeBella, Kimberly ^a   Szudek, Jacek ^a   Friedman, Jan Marshall ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

National Institutes of Health Diagnostic Criteria; Natural history; Neurofibromatosis 1

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; NEUROFIBROMATOSIS; PRIORITY JOURNAL;

EID: 0034094731     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.3.608     Document Type: Article

References (19)

1. Huson SM, Hughes RAC. The Neurofibromatoses. London, UK: Chapman and Hall; 1994;1.3.2:9
2. Littler M, Morton NE. Segregation analysis of peripheral neurofibromatosis (NF1). J Med Genet. 1990;27:307-310
3. Riccardi VM. Neurofibromatosis. 2nd ed. Baltimore, MD: Johns Hopkins University Press; 1992:328-342
4. Clementi M, Barbujani G, Turolla L, Tenconi R. Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet. 1990;84: 116-118
5. North K. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol 1993;8:395-402
6. Stumpf DA, Alksne JF, Annegers JF, et al. Neurofibromatosis: conference statement. Arch Neurol. 1988;45:575-578
7. Gutmann DH, Alysworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51-57
8. Wolkenstein P, Frèche B, Zeller J, Revuz J. Usefulness of screening investigations in neurofibromatosis type 1. Arch Dermatol. 1996;132: 1333-1336
9. Obringer AC, Meadows AT, Zackai EH. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child. 1989; 143:717-719
10. Korf BR. Diagnostic outcome in children with multiple café au lait spots. Pediatrics. 1992;90:924-927
11. Cnossen MH, Smit FJ, de Goede-Bolder A, Frets PG, Duivenvoorden HJ, Niermeijer MF. Diagnostic delay in neurofibromatosis type 1. Eur J Pediatr. 1997;156:482-487
12. Friedman JM, Birch P, Greene C, National Neurofibromatosis Foundation International Database participants. National Neurofibromatosis Foundation International Database. Am J Med Genet. 1993;45:88-91
13. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice Hall; 1984: 378-379
14. Carey JC, Laub JM, Hall BD. Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects: Original Article Series. 1979;5B:271-281
15. Samuelsson B, Axelsson R. Neurofibromatosis: a clinical and genetic study of 96 cases in Gothenburg, Sweden. Acta Derm Venereol. 1981; 95(suppl):67-71
16. Cnossen MH, Moons KGM, Garssen MPJ, et al. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children ≤6 years and clinically suspected of having NF1. J Med Genet. 1998;35:624-627
17. Curless RG, Siatkowski M, Glaser JS, Shatz NJ. MRI Diagnosis of NF-1 in children without café-au-lait skin lesions. Pediatr Neurol. 1998;18:269-271
18. Goldstein SM, Curless RG, Donovan Post MJ, Quencer RM. A new sign of neurofibromatosis on magnetic resonance imaging of children. Arch Neurol 1989;46:1222-1224
19. DiMario FJ, Ramsby G, Greenstein R, et al. Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol. 1993;8:32-39